Vered Bisker-Leib
2021
In 2021, Vered Bisker-Leib earned a total compensation of $4.5M as President and Chief Operating Officer at Compass Therapeutics, a 73% increase compared to previous year.
Compensation breakdown
| Bonus | $320,000 |
|---|---|
| Option Awards | $1,432,000 |
| Salary | $400,000 |
| Stock Awards | $2,298,000 |
| Total | $4,450,000 |
Bisker-Leib received $2.3M in stock awards, accounting for 52% of the total pay in 2021.
Bisker-Leib also received $320K in bonus, $1.4M in option awards and $400K in salary.
Rankings
In 2021, Vered Bisker-Leib's compensation ranked 2,982nd out of 12,406 executives tracked by ExecPay. In other words, Bisker-Leib earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,982 out of 12,406 | 76th |
Division Manufacturing | 1,196 out of 5,492 | 78th |
Major group Chemicals And Allied Products | 481 out of 2,368 | 80th |
Industry group Drugs | 424 out of 2,089 | 80th |
Industry Biological Products, Except Diagnostic Substances | 119 out of 452 | 74th |
Source: SEC filing on April 28, 2022.
Bisker-Leib's colleagues
We found two more compensation records of executives who worked with Vered Bisker-Leib at Compass Therapeutics in 2021.